Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EU Drug Advertising, E-Commerce Working Groups To Be Formed By 2000

Executive Summary

The European Commission's Pharmaceutical Committee plans to establish ad hoc working groups on advertising and electronic commerce by late 1999 or early 2000.

You may also be interested in...



EMEA/Eastern Block To Form Drug Regulation Action Plan In February

EU regulators and their counterparts from Central and Eastern European countries will meet in Budapest in early February to form an action plan for the European Commission's Pan-European Regulatory Forum (PERF) for pharmaceuticals.

P&U "Dear Doctor" Letter Notes New Label Warning For Sleep Onset

Pharmacia & Upjohn plans to conduct studies of Mirapex (pramipexole) in response to an increasing number of reports of sudden sleep onset during daily activities, the company said.

Pharmacia & Upjohn Discussing Mirapex Sudden Sleep Onset With FDA

FDA and Pharmacia & Upjohn are discussing possible labeling changes to the Parkinson's therapy Mirapex (pramipexole) to reflect reports of sudden sleep onset in patients.

Related Content

UsernamePublicRestriction

Register

PS035040

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel